By Matthew Finston : Deception of SBAC SBA Communications' (NASDAQ: SBAC ) recent quarterly report suggests the company is improving dramatically, but is it enough to justify current valuation? Although revenue has increased 18% YoY, revenue per share has in fact merely increased 9%. That's because
athenahealth ( ATHN -2.1% ) Q2 results: Total Revenue: $185,922K (+27.1%); Business Services: $175,949K (+27.6%); R&D
athenahealth (NASDAQ: ATHN ): Q2 EPS of $0.32 beats by $0.10 . Revenue of $185.9M (+27.1% Y/Y) beats by $3.76M . Shares +5.65% AH. Press Release Post your comment!
come for Mr. Jonathan Bush's athenahealth (NASDAQ: ATHN ) to once again put up or shut ..... the marketplace. Bulls love athenahealth because of the newly created ..... out which direction is next for ATHN . As you can see the stock has
AMD , ASBC , ATHN , BGS , CE , COF , CPHD , CYT , EFII , GOOG , GRT , IBM , PBCT , SLB , STX , SWKS , SYK , VMI , WAL Post your comment!
reports; pg 27]. Pg 20: Recommendations from Sohn conference . Ackman /Pershing Square: FNMA Einhorn /Greenlight: Short ATHN Gordon /Daruma: EFII, FUL, PCRX Grant /Grant: OGZPY Guichon /Columbia MBA Program: FIATY Gundlach /DoubleLine: Short
small-cap chemical co Innophos Holdings [ IPHS ; pg 24]; internet-based medical records and billing company Athenahealth [ ATHN ; fee of 4% of billings; a mixed view; skeptical on gains in the hospital market; pg 40]; J&J [ JNJ ; CEO
possible. That trend started with electronic medical records and still continues. Going forward, companies like Athenahealth (NASDAQ: ATHN ) which saw a 53 percent gain last year, are compelling plays in that space. Yet, there’s another space
We are no longer providing equity research on AthenaHealth ATHN . We provide broad coverage of more than 1,700 companies across more than 140 industries and adjust our coverage as necessary based on client demand and investor interest.
We are slightly increasing athenahealth 's ATHN fair value estimate after reviewing the company's fourth ..... line growth. This news is not altogether surprising-- athenahealth has long needed to invest heavily in order to compete with